These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 17255677)

  • 1. Management of vasospastic disorders with botulinum toxin A.
    Van Beek AL; Lim PK; Gear AJL; Pritzker MR
    Plast Reconstr Surg; 2007 Jan; 119(1):217-226. PubMed ID: 17255677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Botulinum Toxin A Salvage of Ischemic Hand Trauma.
    Laarakker AS; Borah G
    Plast Reconstr Surg; 2020 Jan; 145(1):161-164. PubMed ID: 31881617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Botulinum toxin type A: a treatment option for digital ischemia in patients with Raynaud's phenomenon.
    Fregene A; Ditmars D; Siddiqui A
    J Hand Surg Am; 2009 Mar; 34(3):446-52. PubMed ID: 19258141
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botox therapy for ischemic digits.
    Neumeister MW; Chambers CB; Herron MS; Webb K; Wietfeldt J; Gillespie JN; Bueno RA; Cooney CM
    Plast Reconstr Surg; 2009 Jul; 124(1):191-201. PubMed ID: 19568080
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Botulinum toxin type A contribution in the treatment of Raynaud's phenomenon due to systemic sclerosis].
    Serri J; Legré R; Veit V; Guardia C; Gay AM
    Ann Chir Plast Esthet; 2013 Dec; 58(6):658-62. PubMed ID: 22204894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum Toxin for the Treatment of Intractable Raynaud Phenomenon.
    Gallegos JE; Inglesby DC; Young ZT; Herrera FA
    J Hand Surg Am; 2021 Jan; 46(1):54-59. PubMed ID: 32948347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Use of Botulinum Toxin in Raynaud Phenomenon: A Comprehensive Literature Review.
    Lawson O; Sisti A; Konofaos P
    Ann Plast Surg; 2023 Jul; 91(1):159-186. PubMed ID: 37450876
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of botulinum toxin in vasospastic disorders of the hand.
    Neumeister MW
    Hand Clin; 2015 Feb; 31(1):23-37. PubMed ID: 25455354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case report of the beneficial effects of botulinum toxin type A on Raynaud phenomenon in a patient with lung cancer.
    Wang L; Lei QS; Liu YY; Song GJ; Song CL
    Medicine (Baltimore); 2016 Oct; 95(40):e5092. PubMed ID: 27749585
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Effects of Botulinum Toxin A on Pain in Ischemic Vasospasm.
    Goldberg SH; Akoon A; Kirchner HL; Deegan J
    J Hand Surg Am; 2021 Jun; 46(6):513.e1-513.e12. PubMed ID: 33431193
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischaemic ulcers on the toes secondary to Raynaud phenomenon in a patient with systemic sclerosis successfully treated with botulinum toxin.
    Garrido-Ríos AA; González-Olivares M; Navarro-Vidal B; Martínez-Morán C; Borbujo J
    Clin Exp Dermatol; 2018 Jun; 43(4):503-505. PubMed ID: 29274125
    [No Abstract]   [Full Text] [Related]  

  • 12. Injection of botulinum toxin for the treatment of post-laryngectomy pharyngoesophageal spasm-related disorders.
    Lightbody KA; Wilkie MD; Kinshuck AJ; Gilmartin E; Lewis-Jones H; Jones TM; Lancaster J
    Ann R Coll Surg Engl; 2015 Oct; 97(7):508-12. PubMed ID: 26414361
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Marked effect of botulinum toxin A for severe toe digital ulcers in a patient with systemic sclerosis].
    Nielsen JB; Hvid L; Olesen AB
    Ugeskr Laeger; 2014 Feb; 176(8A):V08130527. PubMed ID: 25350310
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted high concentration botulinum toxin A injections in patients with Raynaud's phenomenon: a retrospective single-centre experience.
    Nagarajan M; McArthur P
    Rheumatol Int; 2021 May; 41(5):943-949. PubMed ID: 32447423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Head and neck muscle spasm after radiotherapy: management with botulinum toxin A injection.
    Van Daele DJ; Finnegan EM; Rodnitzky RL; Zhen W; McCulloch TM; Hoffman HT
    Arch Otolaryngol Head Neck Surg; 2002 Aug; 128(8):956-9. PubMed ID: 12162778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Botulinum toxin type A in the treatment of Raynaud's phenomenon.
    Neumeister MW
    J Hand Surg Am; 2010 Dec; 35(12):2085-92. PubMed ID: 21134617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Botulinum toxin-A for the treatment of Raynaud syndrome.
    Smith L; Polsky D; Franks AG
    Arch Dermatol; 2012 Apr; 148(4):426-8. PubMed ID: 22508867
    [No Abstract]   [Full Text] [Related]  

  • 18. Optimisation of botulinum toxin type a treatment for the management of Raynaud's phenomenon using a dorsal approach: a prospective case series.
    Dhaliwal K; Griffin MF; Salinas S; Howell K; Denton CP; Butler PEM
    Clin Rheumatol; 2019 Dec; 38(12):3669-3676. PubMed ID: 31482318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Raynaud's digital ulcer with interdigital Botulinum toxin A injection.
    Navarro EP; Cañas CA; Tobón GJ
    Rheumatology (Oxford); 2016 Jul; 55(7):1216. PubMed ID: 27155203
    [No Abstract]   [Full Text] [Related]  

  • 20. Role and rationale for extended periarterial sympathectomy in the management of severe Raynaud syndrome: techniques and results.
    Merritt WH
    Hand Clin; 2015 Feb; 31(1):101-20. PubMed ID: 25455361
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.